文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

危重患者急性肾损伤生物标志物轨迹模式的前瞻性观察研究

Trajectory pattern of serially measured acute kidney injury biomarkers in critically ill patients: a prospective observational study.
PubMed 文献 · Ann Intensive Care · 2024-06-06
一句话结论在ICU患者中,连续测量的尿L-FABP轨迹模式与出院时主要肾脏不良事件(MAKE)显著相关,其中「高且指数上升」组MAKE发生率达100%。

这项单中心前瞻性观察研究纳入156例成人ICU患者,在入ICU后0、12、24、48小时连续测量血eGFR、血浆NGAL和尿L-FABP。基于组轨迹建模分析,eGFR和血浆NGAL的轨迹曲线呈平行移动(低、中、高),而uL-FABP呈现三种不同方向轨迹:「低且恒定」「高且指数下降」「高且指数上升」。uL-FABP轨迹模式与MAKE显著相关,三组MAKE发生率分别为18%、40%和100%(P<0.001);校正eGFR后,uL-FABP初始值和12小时变化均与MAKE显著相关。

要点

  • uL-FABP轨迹呈「高且指数上升」组MAKE发生率100%(9/9),「高且指数下降」组40%(16/40),「低且恒定」组18%(16/89),三组差异P<0.001。
  • 校正eGFR后,uL-FABP初始值每增加1个log单位,MAKE的OR为1.45(95%CI 1.17-1.83);12小时变化每增加1个log单位,OR为1.43(95%CI 1.12-1.88)。
  • eGFR和血浆NGAL的轨迹曲线呈平行移动(低、中、高),而uL-FABP轨迹呈不同方向变化,提示uL-FABP轨迹模式具有独立于eGFR的关联。
  • 研究纳入有动脉置管和尿管的成人ICU患者,排除ICU停留<48小时及已知终末期肾病患者,入组时间为2014年9月至2015年3月。

适用人群与场景

  • 日本东京一家教学医学机构混合ICU的成人患者,需有动脉置管和尿道尿管,入组时间2014年9月至2015年3月。
  • 排除ICU停留时间<48小时的患者和已知终末期肾病患者。

诊断标准与关键阈值

  • MAKE(主要肾脏不良事件)定义为出院时死亡、透析依赖和持续性肾功能丧失(eGFR下降≥25%)的复合终点。
  • 基于组轨迹建模分析,将eGFR、血浆NGAL和uL-FABP各变量分别分为三组。

研究设计与关键结果

  • 单中心前瞻性观察研究,纳入156例成人ICU患者,在入ICU后0、12、24、48小时连续测量血eGFR、血浆NGAL和uL-FABP。
  • eGFR和血浆NGAL的轨迹曲线呈平行移动(低、中、高),而uL-FABP曲线呈现三种不同方向轨迹:「低且恒定」「高且指数下降」「高且指数上升」。
  • uL-FABP轨迹模式与MAKE显著相关:「低且恒定」组MAKE 16例(18%),「高且指数下降」组16例(40%),「高且指数上升」组9例(100%),P<0.001。
  • 校正eGFR后,uL-FABP初始值(log转换后每增加1点)与MAKE的OR为1.45(95%CI 1.17-1.83),12小时变化(log转换后每增加1点)的OR为1.43(95%CI 1.12-1.88),两者均显著相关。

证据类型、等级与局限

  • 证据类型:单中心前瞻性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,连续测量的尿L-FABP轨迹模式与ICU患者MAKE显著相关,uL-FABP轨迹模式可能为ICU患者肾脏不良事件风险分层提供信息。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The clinical value of the trajectory of temporal changes in acute kidney injury (AKI) biomarkers has not been well established among intensive care unit (ICU) patients.

METHODS: This is a single-center, prospective observational study, performed at a mixed ICU in a teaching medical institute in Tokyo, Japan. Adult ICU patients with an arterial line and urethral catheter were enrolled from September 2014 to March 2015. Patients who stayed in the ICU for less than 48 h and patients with known end-stage renal disease were excluded from the study. Blood and urine samples were collected for measurement of AKI biomarkers at 0, 12, 24, and 48 h after ICU admission. The primary outcome was major adverse kidney events (MAKE) at discharge, defined as a composite of death, dialysis dependency, and persistent loss of kidney function (≥ 25% decline in eGFR).

RESULTS: The study included 156 patients. Serum creatinine-based estimated glomerular filtration rate (eGFR), plasma neutrophil gelatinase-associated lipocalin (NGAL), and urinary liver-type fatty acid-binding protein (uL-FABP) were serially measured and each variable was classified into three groups based on group-based trajectory modeling analysis. While the trajectory curves moved parallel to each other (i.e., "low," "middle," and "high") for eGFR and plasma NGAL, the uL-FABP curves showed distinct trajectory patterns and moved in different directions ("low and constant," "high and exponential decrease," and "high and exponential increase"). These trajectory patterns were significantly associated with MAKE. MAKE occurred in 16 (18%), 16 (40%), and 9 (100%) patients in the "low and constant," "high and exponential decrease," and "high and exponential increase" groups, respectively, based on uL-FABP levels (p-value < 0.001). The initial value and the 12-h change in uL-FABP were both significantly associated with MAKE, even after adjusting for eGFR [Odds ratio (95% confidence interval): 1.45 (1.17-1.83) and 1.43 (1.12-1.88) for increase of initial value and 12-h change of log-transformed uL-FABP by 1 point, respectively].

CONCLUSIONS: Trajectory pattern of serially measured urinary L-FABP was significantly associated with MAKE in ICU patients.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Horie R, Hayase N, Asada T, et al. Trajectory pattern of serially measured acute kidney injury biomarkers in critically ill patients: a prospective observational study. Ann Intensive Care. 2024. PMID: 38842613. doi:10.1186/s13613-024-01328-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。